Lipid-lowering medications are associated with lower risk of retinopathy and ophthalmic interventions among United States patients with diabetes
Purpose To evaluate the impact of lipid-lowering medications on diabetic retinopathy and
diabetic complications requiring intervention in the US population. Design Retrospective …
diabetic complications requiring intervention in the US population. Design Retrospective …
Current epidemiology of diabetic retinopathy and diabetic macular edema
With increasing global prevalence of diabetes, diabetic retinopathy (DR) is set to be the
principle cause of vision impairment in many countries. DR affects a third of people with …
principle cause of vision impairment in many countries. DR affects a third of people with …
[HTML][HTML] Visual impairment and blindness avoided with ranibizumab in Hispanic and non-Hispanic whites with diabetic macular edema in the United States
R Varma, NM Bressler, QV Doan, M Danese, CM Dolan… - Ophthalmology, 2015 - Elsevier
Objective To estimate visual impairment (VI) and blindness avoided with intravitreal
ranibizumab 0.3 mg treatment for central-involved diabetic macular edema (DME) among …
ranibizumab 0.3 mg treatment for central-involved diabetic macular edema (DME) among …
Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource …
Diabetes mellitus (DM) is a global epidemic and affects populations in both developing and
developed countries, with differing health care and resource levels. Diabetic retinopathy …
developed countries, with differing health care and resource levels. Diabetic retinopathy …
Incidence of proliferative diabetic retinopathy and other neovascular sequelae at 5 years following diagnosis of type 2 diabetes
WS Gange, J Lopez, BY Xu, K Lung… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE To determine the incidence and risk factors for developing proliferative diabetic
retinopathy (PDR), tractional retinal detachment (TRD), and neovascular glaucoma (NVG) at …
retinopathy (PDR), tractional retinal detachment (TRD), and neovascular glaucoma (NVG) at …
Real-world outcomes of anti–vascular endothelial growth factor therapy in diabetic macular edema in the United States
TA Ciulla, P Bracha, J Pollack, DF Williams - Ophthalmology Retina, 2018 - Elsevier
Purpose This study assessed real-world visual acuity (VA) outcomes of anti–vascular
endothelial growth factor (anti-VEGF) therapy for diabetic macular edema (DME). Design …
endothelial growth factor (anti-VEGF) therapy for diabetic macular edema (DME). Design …
A telemedicine program for diabetic retinopathy in a veterans affairs medical center—the Joslin vision network eye health care model
AA Cavallerano, JD Cavallerano, P Katalinic… - American journal of …, 2005 - Elsevier
PURPOSE: To extend access to diabetic eye care and characterize the extent of diabetic
retinopathy {DR) and other ocular findings using the Joslin Vision Network (JVN). DESIGN …
retinopathy {DR) and other ocular findings using the Joslin Vision Network (JVN). DESIGN …
American Society of Retina Specialists clinical practice guidelines: management of nonproliferative and proliferative diabetic retinopathy without diabetic macular …
Diabetic retinopathy (DR) is common, preventable, and treatable, with blinding
consequences that affect working-aged adults, making it a major focus of public health …
consequences that affect working-aged adults, making it a major focus of public health …
[HTML][HTML] Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan …
SE Bursell, SJ Fonda, DG Lewis, MB Horton - PloS one, 2018 - journals.plos.org
Background Diabetes and its complications are more common in American Indians and
Alaska Natives (AI/AN) than other US racial/ethnic populations. Prior reports of diabetic …
Alaska Natives (AI/AN) than other US racial/ethnic populations. Prior reports of diabetic …